Stocks · Korea
002620
KOSPI
Jeil Pharma Holdings
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+1.34%
1M-1.18%
3M+12.67%
6M-11.99%
1Y-12.80%
YTD-7.24%
52W high9,850원
52W low6,050원
From 52W high-23.25%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 7,930억 | -75억 | -831억 | -0.9% |
| 2023 | 8,040억 | 208억 | -132억 | 2.6% |
| 2024 | 7,798억 | -116억 | -664억 | -1.5% |
| 2025 | 6,576억 | 387억 | 346억 | 5.9% |
| Quarterly | ||||
| 2024 4Q | 2,040억 | 39억 | -323억 | 1.9% |
| 2025 1Q | 1,820억 | 71억 | 46억 | 3.9% |
| 2025 2Q | 1,598억 | 69억 | 29억 | 4.3% |
| 2025 3Q | 1,614억 | 181억 | 142억 | 11.2% |
| 2025 4Q | 1,544억 | 66억 | 129억 | 4.2% |
| 2026 1Q | 1,504억 | 36억 | 45억 | 2.4% |
Company
Address: 서울특별시 서초구 사평대로 343
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-08-14[기재정정]반기보고서 (2026.06)
- 2026-05-18[기재정정]분기보고서 (2026.03)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-16[첨부정정]사업보고서 (2025.12)
- 2026-03-16사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.